Monday, 28 April 2025
  
Login

Australia's most trusted
source of pharma news

Monday, 28 April 2025
News

New world's biggest pharma crowned

Posted 5 June 2023 AM

There's a new Goliath in town, with Eli Lilly surpassing Johnson & Johnson (J&J) in market capitalisation for the first time since October 1997.

When trading in the US closed last week, Eli Lilly was worth $634.8 billion (US$419.9 billion), while J&J had a market cap of $616.7 billion (US$407.9 billion).

To see the whole article, please login

Popular

$300M windfall for Aussie boss
PBS could become a 'brutal jungle'
KOLs earning most from pharma
Yes... but with a price reduction
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2025 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home